Seoul, South Korea

Na Rae Lee

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 16.2

ph-index = 1


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Na Rae Lee

Introduction

Na Rae Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of bispecific antibodies for cancer treatment. With a total of four patents to his name, Lee's work is paving the way for new therapeutic approaches in oncology.

Latest Patents

Na Rae Lee's latest patents include groundbreaking inventions such as the "Anti-HER2/anti-4-1BB bispecific antibody and use thereof." This patent provides an innovative pharmaceutical composition and method for treating and/or preventing cancer using the bispecific antibody. Another notable patent is the "Anti-EGFR/anti-4-1BB bispecific antibody," which also offers a pharmaceutical composition and method for cancer treatment. These inventions highlight Lee's commitment to advancing cancer therapies.

Career Highlights

Throughout his career, Na Rae Lee has worked with reputable companies in the biotechnology sector. He has been associated with Yuhan Corporation and Abl Bio Inc., where he has contributed to various research and development projects. His expertise in bispecific antibodies has positioned him as a key figure in the fight against cancer.

Collaborations

Na Rae Lee has collaborated with several talented individuals in his field. Notable coworkers include Eun-Jung Lee and Moo Young Song, who have worked alongside him on various projects. Their combined efforts have led to significant advancements in cancer treatment methodologies.

Conclusion

Na Rae Lee's innovative work in the field of biotechnology, particularly in bispecific antibodies, showcases his dedication to improving cancer therapies. His patents and collaborations reflect a commitment to advancing medical science and providing new hope for cancer patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…